Starpharma Holdings Ltd (OTCQX International:SPHRY)

8.90
Delayed Data
As of Apr 25
 0.00 / 0.00%
Today’s Change
4.94
Today|||52-Week Range
13.40
-15.88%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2014

2015

2016

2017
Operating ActivitiesNet Income / Starting Line-13.4M-15.8M-16.5M6.2M
 
 
 
 
 
Depreciation1.0M1.0M677.5K239.8K
 
 
 
 
 
Total Other Cash Flow1.3M668.8K877.6K-15.8M
 
 
 
 
 
Funds From Operations-12.4M-14.1M-14.9M-9.4M
 
 
 
 
 
Funds From/For Other Operating Expenses-2.1M-2.8M-2.0M3.4M
 
 
 
 
 
Net Cash Flow - Operating Activities-10.3M-11.3M-13.0M-12.8M
 
 
 
 
 
 
InvestingDecrease In Investments0.000.0091.0K0.00
 
 
Capital Expenditures-230.4K-543.9K-70.6K-471.3K
 
 
 
 
 
Fixed Asset Disposal----727.6925.1M
 
 
 
Net Cash Flow Investing-230.4K-543.9K21.1K24.6M
 
 
 
 
 
 
FinancingShort Term Borrowings0.00--------
Long Term Borrowings--0.00------
Long Term Debt Reduction-29.4K-26.7K-23.3K-15.8K
 
 
 
 
 
Net Proceeds Stock Sale215.7K17.1M23.7M0.00
 
 
 
 
Common Preferred Redeemed0.000.000.000.00--
Common Dividends0.000.000.00----
Cash Dividends Paid - Total0.000.000.00----
Other Sources - Financing0.000.000.000.00--
Other Uses - Financing0.000.000.000.00--
Net Cash Flow - Financing186.4K17.1M23.7M-15.8K
 
 
 
 
 
 
Exchange RateEffect of Exchange Rate on Cash45.0K513.9K248.9K-349.9K
 
 
 
 
 
 
Net Change In Cash-10.4M5.2M10.8M11.8M